Tavares Cristiane, Maciel Thaís, Burin Sandra, Ambrósio Luciana, Ghisla Sandro, Sampaio Suely, Castro Fabíola
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil.
Universität Konstanz, Konstanz, Germany.
Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):128-34. doi: 10.1016/j.bjhh.2016.03.004. Epub 2016 Apr 14.
Myeloproliferative neoplasms are Philadelphia chromosome-negative diseases characterized by hyperproliferation of mature myeloid cells, associated or not with the Janus kinase 2 tyrosine kinase mutation, JAK2V617F. As there is no curative therapy, researchers have been investigating new drugs to treat myeloproliferative neoplasms, including l-amino acid oxidase from Calloselasma rhodostoma snake venom (CR-LAAO), which is a toxin capable of eliciting apoptosis in several tumor cell lines.
To evaluate the effects of l-amino acid oxidase from C. rhodostoma snake venom in the apoptotic machinery of JAK2-mutated cell lines.
The HEL 92.1.7 and SET-2 cell lines were cultured with l-amino acid oxidase and catalase for 12h at 37°C in 5% carbon dioxide. The cell viability was assessed by the multi-table tournament method, the level of apoptosis was measured by flow cytometry, and the expression of cysteine-dependent aspartate-specific proteases and cleaved Poly(ADP-ribose) polymerase were analyzed by Western blotting.
l-Amino acid oxidase from C. rhodostoma snake venom was cytotoxic to HEL 92.1.7 and SET-2 cells (50% inhibitory concentration=0.15μg/mL and 1.5μg/mL, respectively) and induced apoptosis in a concentration-dependent manner. Cell treatment with catalase mitigated the l-amino acid oxidase toxicity, indicating that hydrogen peroxide is a key component of its cytotoxic effect.The activated caspases 3 and 8 expression and cleaved PARP in HEL 92.1.7 and SET-2 cells confirmed the apoptosis activation by CR-LAAO.
l-Amino acid oxidase from C. rhodostoma snake venom is a potential antineoplastic agent against HEL 92.1.7 and SET-2 JAK2V617F-positive cells as it activates the extrinsic apoptosis pathway.
骨髓增殖性肿瘤是一类不伴有费城染色体的疾病,其特征为成熟髓系细胞过度增殖,与Janus激酶2酪氨酸激酶突变(JAK2V617F)有关或无关。由于尚无治愈性疗法,研究人员一直在研究治疗骨髓增殖性肿瘤的新药,包括来自红口蝮蛇蛇毒的L-氨基酸氧化酶(CR-LAAO),它是一种能够诱导多种肿瘤细胞系凋亡的毒素。
评估红口蝮蛇蛇毒L-氨基酸氧化酶对JAK2突变细胞系凋亡机制的影响。
将HEL 92.1.7和SET-2细胞系与L-氨基酸氧化酶和过氧化氢酶在37℃、5%二氧化碳条件下培养12小时。采用多平板比色法评估细胞活力,通过流式细胞术检测凋亡水平,并通过蛋白质免疫印迹法分析半胱氨酸天冬氨酸特异性蛋白酶和裂解的聚(ADP-核糖)聚合酶的表达。
红口蝮蛇蛇毒L-氨基酸氧化酶对HEL 92.1.7和SET-2细胞具有细胞毒性(半数抑制浓度分别为0.15μg/mL和1.5μg/mL),并以浓度依赖性方式诱导凋亡。用过氧化氢酶处理细胞可减轻L-氨基酸氧化酶的毒性,表明过氧化氢是其细胞毒性作用的关键成分。HEL 92.1.7和SET-2细胞中活化的半胱氨酸天冬氨酸特异性蛋白酶3和8的表达以及裂解的聚(ADP-核糖)聚合酶证实了CR-LAAO激活了凋亡。
红口蝮蛇蛇毒L-氨基酸氧化酶是一种针对HEL 92.1.7和SET-2 JAK2V617F阳性细胞的潜在抗肿瘤药物,因为它激活了外源性凋亡途径。